Murali R - Search Results

1

Disabling receptor ensembles with rationally designed interface peptidomimetics.

Berezov A, Chen J, Liu Q, Zhang HT, Greene MI, Murali R. Berezov A, et al. Among authors: murali r. J Biol Chem. 2002 Aug 2;277(31):28330-9. doi: 10.1074/jbc.M202880200. Epub 2002 May 14. J Biol Chem. 2002. PMID: 12011054 Free article.

2

Study of disabling T-cell activation and inhibiting T-cell-mediated immunopathology reveals a possible inverse agonist activity of CD4 peptidomimetics.

Horie T, Shen Y, Kajino K, Gaubin M, Bonomi G, Mani JC, Berezov A, Piatier-Tonneau D, Guardiola J, Hillard B, Rostami A, Greene M, Murali R. Horie T, et al. Among authors: murali r. Exp Mol Pathol. 2002 Oct;73(2):93-103. doi: 10.1006/exmp.2002.2444. Exp Mol Pathol. 2002. PMID: 12231211

3

Structure-based approaches to inhibition of erbB receptors with peptide mimetics.

Berezov A, Greene MI, Murali R. Berezov A, et al. Among authors: murali r. Immunol Res. 2003;27(2-3):303-8. doi: 10.1385/IR:27:2-3:303. Immunol Res. 2003. PMID: 12857977 Review.

4

Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo.

Cheng X, Kinosaki M, Takami M, Choi Y, Zhang H, Murali R. Cheng X, et al. Among authors: murali r. J Biol Chem. 2004 Feb 27;279(9):8269-77. doi: 10.1074/jbc.M309690200. Epub 2003 Dec 15. J Biol Chem. 2004. PMID: 14679212 Free article.

5

Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent.

Ponde DE, Su Z, Berezov A, Zhang H, Alavi A, Greene MI, Murali R. Ponde DE, et al. Among authors: murali r. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2550-3. doi: 10.1016/j.bmcl.2011.02.013. Epub 2011 Feb 15. Bioorg Med Chem Lett. 2011. PMID: 21392985 Free PMC article.

6

Structure of Sad1-UNC84 homology (SUN) domain defines features of molecular bridge in nuclear envelope.

Zhou Z, Du X, Cai Z, Song X, Zhang H, Mizuno T, Suzuki E, Yee MR, Berezov A, Murali R, Wu SL, Karger BL, Greene MI, Wang Q. Zhou Z, et al. Among authors: murali r. J Biol Chem. 2012 Feb 17;287(8):5317-26. doi: 10.1074/jbc.M111.304543. Epub 2011 Dec 14. J Biol Chem. 2012. PMID: 22170055 Free PMC article.

7

Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.

Park BW, Zhang HT, Wu C, Berezov A, Zhang X, Dua R, Wang Q, Kao G, O'Rourke DM, Greene MI, Murali R. Park BW, et al. Among authors: murali r. Nat Biotechnol. 2000 Feb;18(2):194-8. doi: 10.1038/72651. Nat Biotechnol. 2000. PMID: 10657127

8

Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis.

Berezov A, Zhang HT, Greene MI, Murali R. Berezov A, et al. Among authors: murali r. J Med Chem. 2001 Aug 2;44(16):2565-74. doi: 10.1021/jm000527m. J Med Chem. 2001. PMID: 11472210

9

The TNF receptor superfamily: role in immune inflammation and bone formation.

Cheng X, Kinosaki M, Murali R, Greene MI. Cheng X, et al. Among authors: murali r. Immunol Res. 2003;27(2-3):287-94. doi: 10.1385/IR:27:2-3:287. Immunol Res. 2003. PMID: 12857975 Review.

10

Fas-disabling small exocyclic peptide mimetics limit apoptosis by an unexpected mechanism.

Hasegawa A, Cheng X, Kajino K, Berezov A, Murata K, Nakayama T, Yagita H, Murali R, Greene MI. Hasegawa A, et al. Among authors: murali r. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6599-604. doi: 10.1073/pnas.0401597101. Epub 2004 Apr 14. Proc Natl Acad Sci U S A. 2004. PMID: 15084739 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters